
Sign up to save your podcasts
Or


In this podcast episode, we review the major FDA approvals in psychopharmacology for 2019. We explore brexanolone, bremelanotide, the asenapine skin patch, esketamine, cariprazine, and lumateperone.
By Psychopharmacology Institute4.6
269269 ratings
In this podcast episode, we review the major FDA approvals in psychopharmacology for 2019. We explore brexanolone, bremelanotide, the asenapine skin patch, esketamine, cariprazine, and lumateperone.

700 Listeners

75 Listeners

497 Listeners

147 Listeners

302 Listeners

3,343 Listeners

158 Listeners

1,353 Listeners

712 Listeners

558 Listeners

472 Listeners

371 Listeners

715 Listeners

190 Listeners

154 Listeners